click below
click below
Normal Size Small Size show me how
WEEK 18:
Respiratory tract infections - TB:
| Question | Answer |
|---|---|
| mycobacterium tuberculosis structure and staining | modified peptidoglycan layer with mycolic acid waxy coat (lipids), and has a poor gram stain due to high lipid content (lipids are less permeable to gram stain) so acid fast stain (Zeihl-Neelsen stain) is needed to colourise TB for light microscopy |
| mycobacterium tuberculosis | slow growing obligate aerobes (NEED O2) and facultative intracellular bacteria (invades macrophages and dendritic cells) |
| pathogenesis of active primary TB | affects upper lobes creating a ghon focus (caseous necrosis) and ghon complex (a ghon focus in lymph nodes) which usually resolves but can produce calcified granuloma/ area of scar tissue and may be an area leading to secondary (reactivated) TB |
| pathogenesis of secondary (reactivation) of TB | reactivated of primary TB site, common in immunocompromised and is treated with monoclonal antibodies |
| definition of latent disease of TB | persistent immune response to stimulation by mycobacterium tuberculosis antigens with no evidence of clinically active TB |
| clinical course of TB | cell mediated immunity occurs 2-8 weeks after infection (associated with tuberculin skin test). Activated T lymphocytes and macrophages form caseating granulomas that limit spread and replication where most patients are asymptomatic with latent infection |
| clinical findings of TB (7) | cough, SOB, haemoptysis, chest pain, fever, and especially drenching night sweats, and weight loss |
| diagnosis of TB (2) | suspected in anyone with high risk of developing TB and has general symptoms eg night sweats |
| post complications of pulmonary TB can lead to | post TB bronchiectasis, COPD, aspergillomas (fungus), post TB corpulmonale (respiratory failure) and death |
| complications of active extrapulmonary TB | miliary spread in lungs due to invasion into bronchus/ lymphatics via pulmonary veins |
| most serious complication of TB | CNS disease |
| how to investigate TB | chest radiograph and screening (mantoux test), staining and cultures |
| active TB will show what on a chest radiograph | consolidation (opacity in upper/ mid lobes), cavitating lesions with or without calcification |
| latent TB will show what on a chest radiograph | nodules and fibrotic changes |
| Mantoux test | tuberculin (cell envelop protein) injected intradermally and skin is inspected for signs of local skin reaction eg swelling after 2-3 days. Test is considered positive at an induration (thickening/hardening) of 5mm or more |
| what happens if patients assessed has no evidence for active infection (based on symptoms and xray) | still be treated for latent TB infection to prevent progression into active disease, using 3 months of isoniazid with pyridoxine and rifampicin or 6 months of isoniazid with pyridoxine |
| drug regimens for patients with latent TB infection | 3 months of isoniazid with pyridoxine and rifampicin or 6 months of isoniazid with pyridoxine |
| bronchoalveolar lavage | best for staining and culture of tissues/CSF/ urine samples to investigate presence of TB |
| sputum cultures | category 3 pathogen and must be handled in category 3 lab |
| how long does it take for cultures to grow | 2-8 weeks |
| antibiotic sensitivity testing importance | find out what the pathogen causing TB is resistant to so we know what to treat them with |
| Bacillus Calmette Guerin (BCG) vaccine | offers limited protection against TB (and leprosy) |
| MDR-TB | multi drug resistant TB (strain of TB resistant to two first line drugs -isoniazid and rifampicin) |
| XDR-TB | extensively drug resistant TB (multidrug resistant TB with additional resistance to any fluroquinolone and also any one of the three specialist second line injectable agents) |
| TB type of hypersensitivity | delayed type |